Instil Bio, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
Instil Bio, Inc. (TIL) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent of 0.00% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch · last filed 2023-03-31
- Instil Bio, Inc. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2022 was 0.00%.
- Instil Bio, Inc. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2021 was -0.90%, a 134.62% decline from fiscal 2020.
- Instil Bio, Inc. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2020 was 2.60%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 12 month as first filed |
|---|---|---|
| 2022-12-31 | 0.00% 10-K · filed 2023-03-31 | |
| 2021-12-31 | -0.90% 10-K · filed 2023-03-31 | 0.90% 10-K · filed 2022-03-07 |
| 2020-12-31 | 2.60% 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |